MedicaMetrix

1 in 8 men will be diagnosed with prostate cancer.

Invest in the Future of Prostate Health

 

MedicaMetrix Corp. is a startup medical device company whose primary focus and mission are to transform patient care through innovative MedTech solutions. Their revolutionary device, the ProstaMetrix System, is a portable, physician’s office medical tech device that turns a digital rectal exam into a next generation cancer screening tool.  Some benefits of the ProstaMetrix System include:

• Aids in determining between indolent and aggressive cancers
• Accurate, real-time results
• Fewer false positive diagnoses 
• Fewer biopsies
• Lower cost
• Allows clinicians to assess and treat other prostate health issues.

Download MedicaMetrix’s Investor Deck to learn more about this investment opportunity!